Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 16, 2024

Data from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis

View Full Paper
Ask AI
Bookmark
Share

Authors

DMDebarati MukherjeeRPRebecca A. PrevisCHCorinne Haines

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mukherjee et al. (2024) studied this question.

synapsesocial.com/papers/68e587eeb6db643587523b52https://doi.org/10.1158/0008-5472.c.6816225.v2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inhibition of the Calcium Calmodulin Kinase Kinase-2/phosphodiesterase-1 signaling pathway as a therapeutic approach in metastatic breast cancer.2024
  2. 2Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis2024
  3. 3Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis2024
  4. 4CK2 in triple-negative breast cancer: oncogenic signaling networks and emerging CK2 inhibitor-based combination therapies2026
  5. 5CK2α-mediated phosphorylation of GRP94 facilitates the metastatic cascade in triple-negative breast cancer2024 · 14 citations